Roll Pain Away Gel
NDC Package 72683-009-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Roll Pain Away (capsaicin) gel is adults and children over 18 years:Apply to affected area. This formulation utilizes a gel delivery system. Marketed by Proximity Capital Partners Llc Dba Asutra, this product is identified by NDC 72683-009 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
72683-009-01
Package Description
96 g in 1 BOTTLE
Product Code
72683-009
11-Digit Billing Format
72683000901

Clinical Specifications

Proprietary Name
Roll Pain Away
Non-Proprietary Name
Capsaicin
Substance Name
Capsaicin
Dosage Form
Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
CAPSAICIN .025 g/100g
Usage Information
Adults and children over 18 years:Apply to affected area. Massage into the painful area until thoroughly absorbed. Repeat as necessary but no more than 3 to 4 times daily. Wash hands with soap and water after applyingChildren 18 years and younger:Consult a doctor.

Regulatory & Marketing

Labeler Name
Proximity Capital Partners Llc Dba Asutra
Product Type
Human Otc Drug
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
06-17-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72683-009-01 identifies a specific commercial package of 96 g in 1 bottle of Roll Pain Away, a human over the counter drug labeled by Proximity Capital Partners Llc Dba Asutra. This gel is formulated for topical use and contains capsaicin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Proximity Capital Partners Llc Dba Asutra on June 17, 2026. The current certification is valid through December 31, 2027.

How is this Proximity Capital Partners Llc Dba Asutra product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72683000901. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72683-009-01
11-Digit CMS (5-4-2)
72683-0009-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.